MYGN — MYRIAD GENETICS INC

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 899923 ·
Last close
$5.54
Market Cap
$530.18M
52W High
$8.09
52W Low
$2.74
ADV30
2,649,513
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 — — — — — — —
Mar 2026 200,400,000 137,600,000 -25,300,000 -34,100,000 673,700,000 124,400,000 336,300,000
Dec 2025 209,800,000 146,800,000 -3,000,000 -7,900,000 706,600,000 149,600,000 338,600,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,400,000
Investing CF
$-25,600,000
Financing CF
$47,600,000
CapEx
$-25,600,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.36
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,156,800,000
Inventory
$27,900,000
Receivables
$123,800,000
ST Investments
—
EBIT TTM
$-386,000,000
Pretax Income TTM
$-399,800,000
Interest Exp TTM
$13,800,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$803,600,000
EBITDA
$-58,300,000
Free Cash Flow
$3,587,500
Enterprise Value
$668,844,032
Total Cash
$107,100,000
Total Debt
$209,400,000
Shares Out
95,700,000
Trailing EPS
$-1.35
Book Value
$2.81
ROE
-40.2%
ROA
-10.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 824,500,000 -67,800,000 -365,900,000 706,600,000 338,600,000 368,000,000 1,800,000
Dec 2024 837,600,000 -88,000,000 -127,300,000 1,027,600,000 326,500,000 701,100,000 -8,700,000
Dec 2023 753,200,000 -144,600,000 -263,300,000 1,146,500,000 363,300,000 783,200,000 -110,900,000
Dec 2022 678,400,000 -123,700,000 -112,000,000 1,198,700,000 312,900,000 885,800,000 -106,300,000

TTM Snapshot

Revenues TTM
$806,600,000
NetIncome TTM
$-112,600,000
OpCashFlow TTM
—
Assets (Latest)
$638,900,000
Forward EPS
$-0.59

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $4.00 · spot: $5.53 · call volume: 214 · put volume: 22

Peers — same industry

TickerNameMarket CapLastDaily %
NRC NRC HEALTH $549.32M $25.89 —
TKNO Alpha Teknova, Inc. $481.21M $7.65 —
QUIT ACHIEVE LIFE SCIENCES, INC. $630.99M $6.12 —
ACHV ACHIEVE LIFE SCIENCES, INC. $666.81M $6.06 —
QDEL QuidelOrtho Corp $677.21M $9.87 —

News headlines (Yahoo Finance, 1h cache)

Myriad Genetics Expands SRL Partnership in Japan to Support Future Growth
2026-11-17 14:05 · Yahoo
Carrier Screening - Global Strategic Business Report 2026: Secure Your Share of a $7.6 Billion Market by 2032 | Features Competitive Intelligence on Illumina, Natera, BGI Genomics, and Myriad Genetics
2026-11-11 14:25 · Yahoo
Myriad Genetics’s Q3 2026 earnings call: our top 5 analyst questions
2026-11-08 23:33 · Yahoo
Myriad Genetics (MYGN) Q3 2026 Earnings Call Transcript
2026-11-05 18:50 · Yahoo
Myriad Genetics, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Myriad Genetics Inc (MYGN) Q3 2026 Earnings Call Highlights: Revenue Guidance Raised as ...
2026-11-05 09:13 · Yahoo
Myriad Genetics (MYGN) Reports Q3 Loss, Beats Revenue Estimates
2026-11-04 23:45 · Yahoo
Myriad: Q3 Earnings Snapshot
2026-11-04 23:17 · Yahoo
Myriad Genetics Q3 Earnings Call Highlights
2026-11-04 23:14 · Yahoo
Myriad Genetics (NASDAQ:MYGN) reports upbeat Q3 2026, stock jumps 10.7%
2026-11-04 21:34 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.